Ironwood Pharmaceuticals, Inc. IRWD

4.13 (0.06) (1.43%) as of 25 Sep
Market cap
$692.4M
P/E
5.2×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
21.38 0.00 0.00 10.76 3.58 17.00 0.00 0.00 0.00 0.00
P/S ratio
1.84 2.01 4.36 4.61 4.57 4.66 4.85 3.82 6.39 6.59
P/FCF ratio
4.29 6.82 10.53 6.92 7.23 10.87 545.92 0.00 0.00 0.00
P/Operating CF
7.31 46.32 53.83 23.92 29.30 35.25 75.30 142.87 (206.82) (94.04)
P/B ratio
0.00 0.00 0.00 2.90 3.12 28.99 0.00 0.00 193.50 27.05
Price to Tangible BV
0.00 0.00 0.00 2.91 3.13 29.36 0.00 0.00 0.00 0.00
EV/Sales
3.09 3.98 5.73 3.98 4.21 4.84 5.39 4.51 6.97 6.81
EV/EBITDA
9.11 14.72 0.00 6.50 7.46 12.87 18.36 0.00 0.00 0.00
EV/Operating CF
7.20 13.52 13.82 5.98 6.66 11.16 215.15 (22.07) (20.65) (71.94)
EV/FCF
7.20 13.54 13.84 5.98 6.66 11.29 606.61 (22.45) (20.11) (62.37)
Quick Ratio
1.08 4.39 0.80 30.28 4.55 15.13 7.22 2.14 4.60 4.06
Current Ratio
1.13 4.69 0.84 30.58 4.61 15.41 7.50 2.23 4.72 4.17
Net Debt/EBITDA
3.68 5.21 (0.64) (1.03) (0.64) 0.47 1.84 (1.73) (66.00) (1.66)
Debt/Assets
147.31% 166.42% 148.14% 36.28% 41.96% 77.47% 101.55% 124.63% 66.06% 52.52%
Debt/Equity
(2.23) (1.94) (2.02) 0.61 0.78 6.92 (4.39) (2.11) 40.63 5.59
Asset Turnover
0.79 0.86 0.56 0.37 0.49 0.81 1.17 0.74 0.45 0.41
Operating CF/Net income
5.29 117.67 (0.18) 1.56 0.50 1.59 0.50 0.25 0.86 0.32
Capex/Depreciation
(0.02) (0.07) (0.17) (0.10) (0.17) (0.52) (1.24) 0.10 (0.21) (9.23)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(8.53%) (0.27%) (654.88%) 27.83% 158.09% (693.71%) (14.85%) 302.77% (305.46%) (100.97%)
ROA
6.42% 0.21% (127.54%) 15.72% 62.68% 22.07% 5.85% (60.22%) (17.78%) (12.30%)
ROIC
57.33% 29.99% (227.77%) 39.69% 31.74% 67.89% 54.61% (218.71%) (5.09%) (24.14%)
Return on Tangible Assets
67.91% 0.59% 2,692.16% 22.99% 89.40% 22.47% 7.73% (182.69%) (44.49%) (26.39%)
Average Days of Receivables
57.61 85.05 106.45 102.64 100.60 114.65 99.89 85.24 100.54 86.41
Research and Development Expense of Revenue
32.12% 31.71% 273.65% 10.78% 17.02% 22.61% 26.85% 29.15% 29.55% 50.92%
Selling, General and Administrative Expense of Revenue
27.78% 41.06% 35.76% 28.25% 26.86% 35.94% 40.25% 63.37% 77.51% 63.25%
Intangible Assets out of Total Assets
0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.27 0.24
Share Based Compensation of Revenue
5.82% 8.49% 7.23% 6.59% 5.39% 8.00% 7.30% 11.69% 10.36% 10.67%
Graham Net Nets
(0.71) (0.67) (0.30) 0.18 0.12 0.00 (0.09) (0.20) (0.15) (0.15)
Graham Number
0.00 0.20 17.98 10.41 16.55 2.43 1.17 7.32 0.00 0.00
Earnings Yield
4.68% (0.02%) (51.97%) 9.29% 27.96% 5.88% (0.77%) (21.31%) (6.25%) (4.50%)
Free Cash Flow Yield
23.29% 14.67% 9.50% 14.45% 13.83% 9.20% 0.18% (5.26%) (5.43%) (1.66%)
Revenue per Share
1.83 2.21 2.85 2.66 2.55 2.44 2.75 2.27 2.00 1.89
Operating CF per Share
0.79 0.65 1.18 1.77 1.61 1.06 0.07 (0.46) (0.68) (0.18)
Capex per Share
0.00 0.00 0.00 0.00 0.00 (0.01) (0.04) 0.01 (0.02) (0.72)
Free Cash Flow per Share
0.78 0.65 1.18 1.77 1.61 1.05 0.02 (0.46) (0.69) (0.90)
Cash per Share
1.33 0.56 0.59 4.26 3.83 2.29 1.14 1.14 1.49 2.11
Shareholders Equity per Share
(1.62) (1.89) (2.23) 4.23 3.73 0.39 (0.60) (1.29) 0.07 0.46
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(1.62) (1.89) (2.23) 4.23 3.73 0.39 (0.60) (1.29) 0.07 0.46
Free Cash Flow
127.01 103.41 183.15 273.63 261.63 166.99 3.80 (69.67) (103.42) (129.91)
Working Capital
31.96 143.52 (42.81) 755.10 583.53 463.67 265.92 146.91 245.57 289.05
Capital Expenditures
(0.03) (0.14) (0.27) (0.14) (0.26) (1.84) (6.92) 1.21 (2.67) (103.98)
Net Current Asset Value
(384.56) (469.87) (584.08) 332.49 224.21 (0.76) (189.15) (261.99) (284.23) (262.92)
EV/EBIT
9.29 15.03 0.00 6.53 7.51 13.19 19.21 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.01 0.38
Net Profit Margin
8.11% 0.25% (226.37%) 42.64% 127.72% 27.26% 5.02% (81.46%) (39.20%) (29.83%)
Price to Operating Income
5.54 7.57 0.00 7.57 8.15 12.70 17.29 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.55 0.45 0.28 0.23 0.20 0.40 0.45 1.56 0.73 0.55
Cash ROIC
22.97% 26.68% 40.08% 15.65% 14.96% 18.59% (0.34%) (20.04%) (18.69%) (6.24%)
Accounts Receivable Turnover
4.60 3.33 3.62 3.58 3.50 3.25 4.32 4.25 4.06 4.59
Accounts Payable Turnover
0.00 0.00 0.00 2.00 1.91 1.02 2.34 2.12 1.13 0.14
Inventory Turnover
— — — 0.00 0.00 4.84 (302.22) (922.56) 21.03 0.62
Average Days of Payables
0.00 0.00 0.00 124.33 224.08 76.93 83.89 165.96 305.00 3,459.10
Days of Inventory on Hand
— — — 0.00 0.00 75.42 9.91 (8.98) 14.05 211.22
Average Receivables
64.32 105.50 122.29 114.75 118.20 119.80 99.10 81.55 73.51 59.69
Average Payables
2.51 4.98 4.16 0.71 0.80 3.07 10.19 15.42 16.83 13.15
Average Inventory
— — — — — 0.65 (0.08) (0.04) 0.91 3.02
Average Assets
373.90 410.99 785.80 1,113.72 843.08 480.99 367.40 468.86 657.75 664.47
Average Common Equity
(281.58) (323.81) 153.04 629.14 334.28 (15.31) (144.81) (93.26) 38.28 80.92

Fold the line items

Columns are period end dates